Moreover, women with polycystic ovary syndrome (PCOS), a common endocrine disorder affecting women of reproductive age and often associated with obesity and insulin resistance, may be particularly interested in the potential benefits of semaglutide

GLP-1, GIP & Inflammation: What These Medications Really Do and What They Dont Joshua Silva, MD Dec 5, 2025 7 min read Updated: Jan 27 Medically authored by Joshua Silva, MD | Evidence-Based Weight Loss at Potere Health MD Quick Answer GLP-1 and GLP-1/GIP medications (such as semaglutide and tirzepatide ) can lower metabolic inflammation by improving insulin resistance, reducing visceral fat, and lowering inflammatory biomarkers such as C-reactive protein (CRP) ., They can also improve cardiometabolic risk markers (e.g., blood pressure) and, for tirzepatide, can improve atherogenic lipoprotein measures including apoB and triglyceride-rich lipoproteins in clinical research settings., They do not treat autoimmune diseases or fibromyalgia directly
What does our remote peptide consultation process actually involve
You Pay Nothing Unless We Win: We work on a contingency fee basis for all Ozempic lawsuits filed through our firm